Cargando…
X-inactivation in the clinical phenotype of fragile X premutation carrier sisters
OBJECTIVE: The purpose of this study is to describe a case series of 4 sisters with discordant clinical phenotypes associated with fragile X–associated tremor/ataxia syndrome (FXTAS) that may be explained by varying CGG repeat sizes and activation ratios (ARs) (the ratio of cells carrying the normal...
Autores principales: | Hall, Deborah A., Robertson-Dick, Erin E., O'Keefe, Joan A., Hadd, Andrew G., Zhou, Lili, Berry-Kravis, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817899/ https://www.ncbi.nlm.nih.gov/pubmed/27066582 http://dx.doi.org/10.1212/NXG.0000000000000045 |
Ejemplares similares
-
Genomic studies in fragile X premutation carriers
por: Lozano, Reymundo, et al.
Publicado: (2014) -
Fragile X Premutation
por: Tassone, Flora, et al.
Publicado: (2014) -
Fragile X-Associated Neuropsychiatric Disorders (FXAND) in Young Fragile X Premutation Carriers
por: Aishworiya, Ramkumar, et al.
Publicado: (2022) -
Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS)
por: Hall, Deborah A., et al.
Publicado: (2020) -
Tremorography in fragile X-associated tremor/ataxia syndrome, Parkinson's disease and essential tremor
por: Robertson, Erin E., et al.
Publicado: (2020)